Avid Bioservices Inc (CDMO)

[freethemice]

So, putting the pieces together. I see these two new phase I trials leading to a phase II trial which combines
the use of bavituximab, Xeloda, and radiotherapy in LARC, along with imaging using I-124-PGN650 to
monitor the treatment before surgery to remove any remaining tumor, and maybe after surgery as well to
detect any recurrence.